Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03495193 · ClinicalTrials.gov registry record · NA

Impact of Exercise in Parkinson's Disease

A NA study of Parkinson Disease, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
4
Enrollment target
1
Study location

NCT03495193: Completed NA study of Parkinson Disease, sponsored by University of Alabama at Birmingham.

NCT03495193 is a NA study of Parkinson Disease that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 4 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03495193, a NA study of Parkinson Disease, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

The goal of this research is to identify an intervention that will improve cognition and sleep in persons with PD.

Primary Outcome

Changes in executive function will be measured by a change in a composite executive function score calculated from the mean of z-scores for Stroop inhibition, Trails B-A, and COWA.

Conditions Studied

Interventions

  • OTHER Exercise training
  • BEHAVIORAL Sleep hygiene

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2017-05-18
Est. Completion 2018-11-30
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT03495193 record still lists

NCT03495193 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Exercise training is the first listed.

NCT03495193 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT03495193 about?

NCT03495193 is a clinical study titled "Impact of Exercise in Parkinson's Disease". The goal of this research is to identify an intervention that will improve cognition and sleep in persons with PD.

What is the current status of trial NCT03495193?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2017-05-18. Estimated completion is 2018-11-30.

What conditions does trial NCT03495193 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT03495193?

The interventions under investigation include: Exercise training (OTHER), Sleep hygiene (BEHAVIORAL).

Who is sponsoring clinical trial NCT03495193?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03495193 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03495193's enrollment target sits among peer trials

4 294th of 297 the lowest of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03495193, the US trial registry maintained by the National Library of Medicine. NCT03495193 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.